6,473 Views
•
12:50 min
•
September 15, 2017
DOI:
Transcript
Automatically generated
The overall goal of this screening assay is to characterize novel endothelial regulators involved in the inflammatory response of interest for designing new therapeutic strategies against inflammatory disorders.This method can help answer key questions in the pathology field such as defining novel endothelial-targeting drugs able to attenuate inflammatory-related diseases.The main advantage of this endothelial protocol is that describes assay technology that establishes the basis for exploring novel mechanisms involved in the regulation of the inflammatory response.Demonstrating this methodology will be Maria Angeles Higueras, a post-doc from our lab and Sandra Herranz, a technician from our lab.To begin, culture MLEC-04 cells in complete DMEM F12 medium supplemented with 10%FBS and Pen-Strep.Incubate the cells in a biological incubator at 37
Summary
Automatically generated
Vasculaire endotheel bepaalt strak leukocyte werving. Onvoldoende leukocyte extravasation draagt bij tot de inflammatoire ziekten bij de mens. Daarom is zoeken naar nieuwe regelgevende elementen van endothelial activering om te ontwerpen van verbeterde therapieën voor inflammatoire aandoeningen. Hier beschrijven we een uitgebreide methodologie om te karakteriseren roman endothelial regelgevers die leukocyte handel tijdens ontsteking kunnen wijzigen.
Read Article
Cite this Article
Higueras, M. Á., Jiménez-García, L., Herranz, S., Hortelano, S., Luque, A. Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response. J. Vis. Exp. (127), e55824, doi:10.3791/55824 (2017).
Copy